ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,002Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 356

$1.71M Total Retail Price of All Prescriptions

Rank: 5 out of 356

802 Patients Receiving at Least One Drug in Part D
47%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 802 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 5,647 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

46% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$143 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LEVOTHYROXINE SODIUM 979 462 1 8
METFORMIN HCL 699 285 2 13
PEN NEEDLE 556 200 3 89
HUMALOG 555 242 4 103
SIMVASTATIN 535 217 5 4
LANTUS SOLOSTAR 481 230 6 98
LANTUS 433 178 7 61
LISINOPRIL 416 221 8 6
INSULIN SYRINGE 364 163 9 82
ATORVASTATIN CALCIUM 287 145 10 21
NOVOLOG 265 72 11 116
NOVOLOG FLEXPEN 256 85 12 125
JANUVIA 229 162 13 153
GABAPENTIN 219 103 14 5
AMLODIPINE BESYLATE 203 121 15 2
HUMULIN R 189 63 16 242
HUMALOG MIX 75-25 178 108 17 224
LOSARTAN POTASSIUM 164 106 18 16
ACTOS 164 104 18 228
DIOVAN 158 93 20 63
CRESTOR 152 72 21 34
GLIMEPIRIDE 151 94 22 60
FUROSEMIDE 139 80 23 3
LEVEMIR FLEXPEN 136 73 24 176
LEVEMIR 128 73 25 240
METFORMIN HCL ER 126 31 26 90
PRAVASTATIN SODIUM 108 49 27 22
FENOFIBRATE 107 43 28 134
JANUMET 106 72 29 194
SYNTHROID 106 56 29 100
HYDROCHLOROTHIAZIDE 100 64 31 19
CALCITRIOL 100 59 31 43
BYETTA 98 25 33 270
LOVASTATIN 91 34 34 56
SERTRALINE HCL 87 13 35 49
NOVOLOG MIX 70-30 FLEXPEN 76 30 36 357
GLYBURIDE 72 21 R 37 92
DIOVAN HCT 72 42 37 146
METOPROLOL TARTRATE 70 23 39 9
NOVOLOG MIX 70-30 70 35 39 369
VICTOZA 3-PAK 67 28 41 376
SENSIPAR 65 65 42 59
LIPITOR 62 28 43 167
POTASSIUM CHLORIDE 61 18 44 12
HYDROCORTISONE 59 11 45 300
HUMALOG MIX 50-50 59 45 45 396
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 0 47 78
ALENDRONATE SODIUM 56 32 48 71
ATENOLOL 55 19 49 25
PIOGLITAZONE HCL 52 37 R 50 424
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.